Cardiac Arrhythmias and Covid-19
Abstract Cardiovascular manifestations of COVID-19 include cardiac rhythm disturbances, whose mechanisms, incidence, and most common types are not well established in this population. Intense inflammatory response and metabolic activity contribute to recurrence of pre-existing arrhythmias, and other arrhythmias can occur due to myocardial injury, acute coronary insufficiency, and electrolyte disturbances. Brady- and tachyarrhythmias, as well as conduction disorders have been described. QT interval prolongation and fatal ventricular arrhythmias ( Torsades de Pointes ) may result from the pathological process or adverse effect of drugs (antiarrhythmics, chloroquine / hydroxychloroquine, azithromycin and antivirals). Patients with congenital heart disease and hemodynamic repercussions, patients with signs of heart failure, pulmonary hypertension, cyanosis, hypoxemia, and those who underwent heart transplantation and immunosuppression are at greater risk. In patients with implantable cardioverter-defibrillators (ICDs), the risk depends on the presence of structural heart disease. In the course of COVID-19, in-person assessment of these patients should be limited to high-risk situations, including syncope, worsening of heart failure and shock delivery by ICDs. Likewise, cardiac implantable electronic device implantation or replacement surgery should be limited to emergency and urgent cases, including symptomatic high-degree atrioventricular block, ICD for secondary prevention and pulse generator replacement due to battery drain.
Main Authors: | , , , , , , , , |
---|---|
Format: | Digital revista |
Language: | English |
Published: |
Sociedade Brasileira de Cardiologia
2021
|
Online Access: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S2359-56472021005012201 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
oai:scielo:S2359-56472021005012201 |
---|---|
record_format |
ojs |
spelling |
oai:scielo:S2359-564720210050122012021-09-01Cardiac Arrhythmias and Covid-19Fagundes,Alexsandro AlvesMelo,Sissy Lara deArmaganijan,LucianaKuniyoshi,RicardoMoraes,Luis Gustavo Belo deBorges,Vanessa Alves GuimarãesScanavacca,MauricioMartinelli Filho,MartinoTeixeira,Ricardo Alkmim Coronavirus Infections Cardiac Arrhythmias Artificial Pacemaker Abstract Cardiovascular manifestations of COVID-19 include cardiac rhythm disturbances, whose mechanisms, incidence, and most common types are not well established in this population. Intense inflammatory response and metabolic activity contribute to recurrence of pre-existing arrhythmias, and other arrhythmias can occur due to myocardial injury, acute coronary insufficiency, and electrolyte disturbances. Brady- and tachyarrhythmias, as well as conduction disorders have been described. QT interval prolongation and fatal ventricular arrhythmias ( Torsades de Pointes ) may result from the pathological process or adverse effect of drugs (antiarrhythmics, chloroquine / hydroxychloroquine, azithromycin and antivirals). Patients with congenital heart disease and hemodynamic repercussions, patients with signs of heart failure, pulmonary hypertension, cyanosis, hypoxemia, and those who underwent heart transplantation and immunosuppression are at greater risk. In patients with implantable cardioverter-defibrillators (ICDs), the risk depends on the presence of structural heart disease. In the course of COVID-19, in-person assessment of these patients should be limited to high-risk situations, including syncope, worsening of heart failure and shock delivery by ICDs. Likewise, cardiac implantable electronic device implantation or replacement surgery should be limited to emergency and urgent cases, including symptomatic high-degree atrioventricular block, ICD for secondary prevention and pulse generator replacement due to battery drain.info:eu-repo/semantics/openAccessSociedade Brasileira de CardiologiaInternational Journal of Cardiovascular Sciences n.ahead 20212021-01-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S2359-56472021005012201en10.36660/ijcs.20200123 |
institution |
SCIELO |
collection |
OJS |
country |
Brasil |
countrycode |
BR |
component |
Revista |
access |
En linea |
databasecode |
rev-scielo-br |
tag |
revista |
region |
America del Sur |
libraryname |
SciELO |
language |
English |
format |
Digital |
author |
Fagundes,Alexsandro Alves Melo,Sissy Lara de Armaganijan,Luciana Kuniyoshi,Ricardo Moraes,Luis Gustavo Belo de Borges,Vanessa Alves Guimarães Scanavacca,Mauricio Martinelli Filho,Martino Teixeira,Ricardo Alkmim |
spellingShingle |
Fagundes,Alexsandro Alves Melo,Sissy Lara de Armaganijan,Luciana Kuniyoshi,Ricardo Moraes,Luis Gustavo Belo de Borges,Vanessa Alves Guimarães Scanavacca,Mauricio Martinelli Filho,Martino Teixeira,Ricardo Alkmim Cardiac Arrhythmias and Covid-19 |
author_facet |
Fagundes,Alexsandro Alves Melo,Sissy Lara de Armaganijan,Luciana Kuniyoshi,Ricardo Moraes,Luis Gustavo Belo de Borges,Vanessa Alves Guimarães Scanavacca,Mauricio Martinelli Filho,Martino Teixeira,Ricardo Alkmim |
author_sort |
Fagundes,Alexsandro Alves |
title |
Cardiac Arrhythmias and Covid-19 |
title_short |
Cardiac Arrhythmias and Covid-19 |
title_full |
Cardiac Arrhythmias and Covid-19 |
title_fullStr |
Cardiac Arrhythmias and Covid-19 |
title_full_unstemmed |
Cardiac Arrhythmias and Covid-19 |
title_sort |
cardiac arrhythmias and covid-19 |
description |
Abstract Cardiovascular manifestations of COVID-19 include cardiac rhythm disturbances, whose mechanisms, incidence, and most common types are not well established in this population. Intense inflammatory response and metabolic activity contribute to recurrence of pre-existing arrhythmias, and other arrhythmias can occur due to myocardial injury, acute coronary insufficiency, and electrolyte disturbances. Brady- and tachyarrhythmias, as well as conduction disorders have been described. QT interval prolongation and fatal ventricular arrhythmias ( Torsades de Pointes ) may result from the pathological process or adverse effect of drugs (antiarrhythmics, chloroquine / hydroxychloroquine, azithromycin and antivirals). Patients with congenital heart disease and hemodynamic repercussions, patients with signs of heart failure, pulmonary hypertension, cyanosis, hypoxemia, and those who underwent heart transplantation and immunosuppression are at greater risk. In patients with implantable cardioverter-defibrillators (ICDs), the risk depends on the presence of structural heart disease. In the course of COVID-19, in-person assessment of these patients should be limited to high-risk situations, including syncope, worsening of heart failure and shock delivery by ICDs. Likewise, cardiac implantable electronic device implantation or replacement surgery should be limited to emergency and urgent cases, including symptomatic high-degree atrioventricular block, ICD for secondary prevention and pulse generator replacement due to battery drain. |
publisher |
Sociedade Brasileira de Cardiologia |
publishDate |
2021 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S2359-56472021005012201 |
work_keys_str_mv |
AT fagundesalexsandroalves cardiacarrhythmiasandcovid19 AT melosissylarade cardiacarrhythmiasandcovid19 AT armaganijanluciana cardiacarrhythmiasandcovid19 AT kuniyoshiricardo cardiacarrhythmiasandcovid19 AT moraesluisgustavobelode cardiacarrhythmiasandcovid19 AT borgesvanessaalvesguimaraes cardiacarrhythmiasandcovid19 AT scanavaccamauricio cardiacarrhythmiasandcovid19 AT martinellifilhomartino cardiacarrhythmiasandcovid19 AT teixeiraricardoalkmim cardiacarrhythmiasandcovid19 |
_version_ |
1756441656760991744 |